Non AstraZeneca vaccine to be offered to people under 30 years
Coronavirus Vaccine: The European Medicines Agency (EMA), in a statement released on Wednesday, did not announce any new restrictions regarding the use of vaccines for people 18 years and older.
8th April, 2021
The UK drug regulator has said that the anti-Corona virus anti-AstraZeneca vaccine has wide benefits, but due to rare cases of blood clots, people under the age of 30 will be offered another vaccine. The country's 'Medicines and Healthcare Products Regulatory Agency (MHRA) said on Wednesday that as long as it is studying the association between the AstraZeneca vaccine and rare blood clots, people in the respective age groups should be referred to the Pfizer and Moderna company. Should be vaccinated.
The head of MHRA, Dr. June Raine, said that the benefits of the AstraZeneca vaccine are greater in most people than the risks. The decision was announced shortly after the European Union's drug regulator stated that it had detected a "possible connection" between AstraZeneca's vaccine and rare blood clots. However, it also said that the benefits of this vaccine are still more than the risks.
The European Medicines Agency (EMA), in a statement released on Wednesday, did not announce any new restrictions on the use of vaccines for people 18 years and older. Earlier this week, a senior agency official said that a causal connection was found between AstraZeneca vaccines and rare blood clots in dozens of thousands of people worldwide.
"It is becoming very difficult to say that between the extremely rare blood clots associated with AstraZeneca vaccines and platelet depletion," Marco Cavalleri, Amsterdam-based agency's head of health risk and vaccine strategy, told a Rome newspaper on Tuesday. There is no causal contact. ''
The agency said that its evaluation has not yet reached a conclusion and the review is currently underway.
EMA Executive Director Emer Cook said, "The alleged cases of abnormal blood clots after AstraZeneca have been vaccinated should be considered as potential side effects of
the vaccine ." Between AstraZeneca's vaccine and rare clots in the blood Immediately following the EMA's statement of "potential contact" detection, the UK drug regulator said the Coronavirus anti-AstraZeneca vaccine has extensive benefits, but that rare cases of blood clots occur under the age of 30. People will be offered other vaccines.
Disclaimer: This news has been published directly from the Syndicate feed. It has not been edited by our team.